BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23547048)

  • 1. Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease.
    Denburg MR; Tsampalieros AK; de Boer IH; Shults J; Kalkwarf HJ; Zemel BS; Foerster D; Stokes D; Leonard MB
    J Clin Endocrinol Metab; 2013 May; 98(5):1930-8. PubMed ID: 23547048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric bone mineral density and bone structure in childhood chronic kidney disease.
    Wetzsteon RJ; Kalkwarf HJ; Shults J; Zemel BS; Foster BJ; Griffin L; Strife CF; Foerster DL; Jean-Pierre DK; Leonard MB
    J Bone Miner Res; 2011 Sep; 26(9):2235-44. PubMed ID: 21590737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine serum biomarkers, but not dual-energy X-ray absorptiometry, correlate with cortical bone mineral density in children and young adults with chronic kidney disease.
    Lalayiannis AD; Crabtree NJ; Ferro CJ; Askiti V; Mitsioni A; Biassoni L; Kaur A; Sinha MD; Wheeler DC; Duncan ND; Popoola J; Milford DV; Long J; Leonard MB; Fewtrell M; Shroff R
    Nephrol Dial Transplant; 2021 Sep; 36(10):1872-1881. PubMed ID: 33094322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation.
    Mostoufi-Moab S; Brodsky J; Isaacoff EJ; Tsampalieros A; Ginsberg JP; Zemel B; Shults J; Leonard MB
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3584-92. PubMed ID: 22865901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome.
    Tsampalieros A; Gupta P; Denburg MR; Shults J; Zemel BS; Mostoufi-Moab S; Wetzsteon RJ; Herskovitz RM; Whitehead KM; Leonard MB
    J Bone Miner Res; 2013 Mar; 28(3):480-8. PubMed ID: 23044926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Mineral Accrual Is Associated With Parathyroid Hormone and 1,25-Dihydroxyvitamin D Levels in Children and Adolescents.
    DeBoer MD; Weber DR; Zemel BS; Denburg MR; Herskovitz R; Long J; Leonard MB
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3814-21. PubMed ID: 26241322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
    Taha W; Chin D; Silverberg AI; Lashiker L; Khateeb N; Anhalt H
    Pediatrics; 2001 May; 107(5):E79. PubMed ID: 11331729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D bioavailability and catabolism in pediatric chronic kidney disease.
    Denburg MR; Kalkwarf HJ; de Boer IH; Hewison M; Shults J; Zemel BS; Stokes D; Foerster D; Laskin B; Ramirez A; Leonard MB
    Pediatr Nephrol; 2013 Sep; 28(9):1843-53. PubMed ID: 23728936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays.
    Jemielita TO; Leonard MB; Baker J; Sayed S; Zemel BS; Shults J; Herskovitz R; Denburg MR
    Osteoporos Int; 2016 Feb; 27(2):617-26. PubMed ID: 26359185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in bone structure and the muscle-bone unit in children with chronic kidney disease.
    Tsampalieros A; Kalkwarf HJ; Wetzsteon RJ; Shults J; Zemel BS; Foster BJ; Foerster DL; Leonard MB
    Kidney Int; 2013 Mar; 83(3):495-502. PubMed ID: 23032560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal manifestations of renal disease in childhood.
    Denburg MR
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):292-300. PubMed ID: 27219042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 24,25-dihydroxyvitamin D concentrations in osteogenesis imperfecta: relationship to bone parameters.
    Edouard T; Husseini A; Glorieux FH; Rauch F
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1243-9. PubMed ID: 22319032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of calcifediol supplementation on markers of chronic kidney disease-mineral and bone disorder in dogs with chronic kidney disease.
    Parker VJ; Rudinsky AJ; Benedict JA; Beizaei A; Chew DJ
    J Vet Intern Med; 2020 Nov; 34(6):2497-2506. PubMed ID: 33128421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
    Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid cortical bone loss in patients with chronic kidney disease.
    Nickolas TL; Stein EM; Dworakowski E; Nishiyama KK; Komandah-Kosseh M; Zhang CA; McMahon DJ; Liu XS; Boutroy S; Cremers S; Shane E
    J Bone Miner Res; 2013 Aug; 28(8):1811-20. PubMed ID: 23456850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study.
    Bansal N; Katz R; de Boer IH; Kestenbaum B; Siscovick DS; Hoofnagle AN; Tracy R; Laughlin GA; Criqui MH; Budoff MJ; Li D; Ix JH
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4890-8. PubMed ID: 24092825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.